| Date | Description |
|---|
| 2025-05-12 |
insert associated_investor TVM Capital |
| 2025-02-10 |
insert about_pages_linkeddomain baselarea.swiss |
| 2025-02-10 |
insert about_pages_linkeddomain gewbasel.ch |
| 2023-10-16 |
insert coo Benedict Staehelin |
| 2023-10-16 |
delete address POLYNEURON AWARDED GRANT OF CHF 1.2M
POLYNEURON AWARDED GRANT OF CHF 1.2M |
| 2023-10-16 |
insert email be..@bs.ch |
| 2023-10-16 |
insert person Benedict Staehelin |
| 2023-06-19 |
insert address POLYNEURON AWARDED GRANT OF CHF 1.2M
POLYNEURON AWARDED GRANT OF CHF 1.2M |
| 2023-04-21 |
insert ceo Christian Harr |
| 2023-04-21 |
update person_title Alen Zulji: Interim Head => Financial Advisory |
| 2023-04-21 |
update person_title Christian Harr: COO and Safety Representative => CEO |
| 2023-03-12 |
delete address POLYNEURON AWARDED GRANT OF CHF 1.2M
POLYNEURON AWARDED GRANT OF CHF 1.2M |
| 2022-11-03 |
delete address BIOVERSYS SUCCESSFULLY COMPLETES PHASE I CLINICAL TRIALS OF BVL-GSK098
by Tech Park Basel |